Brief: Venus Medtech Hangzhou Says FY Revenue RMB276.0 Mln
31/03/2021 14:39
March 31 (Reuters) - Venus Medtech Hangzhou Inc 2500.HK :
* FY REVENUE RMB276.0 MILLION VERSUS RMB233.3 MILLION
* FY LOSS ATTRIBUTABLE RMB182 MILLION VERSUS LOSS RMB380.7
MILLION
Source text https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0331/2021033102280.pdf
Further company coverage: 2500.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Medtech (Hangzhou)
See all newsBrief: Venus Medtech Hangzhou To Issue 184.5 Million Shares And HK$379.7 Million Convertible Bonds
Brief: Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million
Brief: Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive Director
Brief: Venus Medtech Hangzhou Logs FY Revenue RMB 306.8 Mln
Brief: Venus Medtech Says Unaware Of Any Info Needing Disclosure To Avoid False Market